Yvan Arsenijevic

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Diabetic Retinopathy

Top Venues

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yvan Arsenijevic, Ning Chang, Olivier Mercey, Younes El Fersioui, Hanna Koskiniemi-Kuendig, Caroline Joubert, Alexis Pierre Bemelmans, Carlo Rivolta, Eyal Banin, Dror Sharon, Paul Guichard, Virginie Hamel, Corinne Kostic
Fine-tuning FAM161A gene augmentation therapy to restore retinal function. EMBO molecular medicine 16 (4) (2024)
Yvan Arsenijevic, Ning Chang, Olivier Mercey, Younes El Fersioui, Hanna Koskiniemi-Kuendig, Caroline Joubert, Alexis Pierre Bemelmans, Carlo Rivolta, Eyal Banin, Dror Sharon, Paul Guichard, Virginie Hamel, Corinne Kostic
Fine-tuning FAM161A gene augmentation therapy to restore retinal function. EMBO molecular medicine 16 (4) (2024)
Yvan Arsenijevic, Ning Chang, Olivier Mercey, Younes El Fersioui, Hanna Koskiniemi-Kuendig, Caroline Joubert, Alexis Pierre Bemelmans, Carlo Rivolta, Eyal Banin, Dror Sharon, Paul Guichard, Virginie Hamel, Corinne Kostic
Fine-tuning FAM161A gene augmentation therapy to restore retinal function. EMBO molecular medicine (2024)
Yvan Arsenijevic, Ning Chang, Olivier Mercey, Younes El Fersioui, Hanna Koskiniemi-Kuendig, Caroline Joubert, Alexis Pierre Bemelmans, Carlo Rivolta, Eyal Banin, Dror Sharon, Paul Guichard, Virginie Hamel, Corinne Kostic
Fine-tuning FAM161A gene augmentation therapy to restore retinal function. EMBO molecular medicine 16 (4) (2024)
Yvan Arsenijevic, Ning Chang, Olivier Mercey, Younes El Fersioui, Hanna Koskiniemi-Kuendig, Caroline Joubert, Alexis Pierre Bemelmans, Carlo Rivolta, Eyal Banin, Dror Sharon, Paul Guichard, Virginie Hamel, Corinne Kostic
Fine-tuning FAM161A gene augmentation therapy to restore retinal function. EMBO molecular medicine 16 (4) (2024)